DalsnaFinance › IPOs › UroGen Pharma Ltd.
UroGen Pharma Ltd. completed its initial public offering on NASDAQ on May 4, 2017, pricing at $13.00 a share.
| Ticker | URGN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 4, 2017 |
| Offering price | $13.00 |
| Shares offered | 4,473,373 |
| Total raised | $58M |
UroGen Pharma Ltd. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.